���ϸ�����

News from ���ϸ����� Langone Health

1 In 4 NY Hospitals Earn Top Patient Safety Grades, Report Shows. (Crain's New York Business)

(5/1) An article about New York hospitals scoring well in a patient safety report from the Leapfrog Group says ���ϸ����� Langone Health “got top marks” at its Tisch Hospital, Kimmel Pavilion, and ���ϸ����� Langone Orthopedic Hospital in Manhattan; ���ϸ����� Langone Hospital—Long Island, and ���ϸ����� Langone Hospital—Brooklyn.

Also reporting is (5/1).

ER Doctors Say This Is The One Thing They Would Never, Ever Do. (Good Housekeeping)

(4/30) Discussing the importance of avoiding needless risks in daily activities, Christine DeSanno-Caridi, DO, clinical associate professor, and chief, Department of Emergency Medicine, ���ϸ����� Langone Hospital—Suffolk, said, “Emergency medicine gives you a unique perspective on rare events because we see them all the time. Just because the risk of something is 1% doesn’t mean it won’t happen — it means someone is going to be that 1%. When the downside is severe, even a small risk can be a big deal.”

���ϸ����� Langone Research Links Phthalates With Heart Disease Deaths. (CNN)

(4/30) Research from ���ϸ����� Langone Health has linked phthalates with increased deaths from heart disease around the world.

Gene-Based Blood Test May Predict Melanoma Recurrence. (Healio)

(4/30) A phase 3 study conducted by ���ϸ����� Langone Health and published in The Lancet Oncology, found that monitoring circulating tumor DNA in stage 3 melanoma patients could predict cancer recurrence, with approximately 80% of patients with detectable ctDNA levels experiencing recurrence, according to David Polsky, MD, PhD, the Alfred W. Kopf, M.D. Professor of Dermatologic Oncology, the Ronald O. Perelman Department of Dermatology, professor, Department of Pathology, Perlmutter Cancer Center, who said, “This is why patients with stage 3 melanoma consider going on treatment to get rid of those remaining melanoma cells.”

���ϸ����� Langone Health Physician Discusses Cancer Misinformation. (CBS News Streaming Network)

(5/1) Stacy Loeb, MD, professor, Departments of Urology and Population Health, Perlmutter Cancer Center, discussed online myths and misinformation regarding cancer.

Can This $860 Helmet Fix Your Hair Loss? The Scalp Treatments Gaining Traction Now. (Wall Street Journal)

The (4/25)* Scalp spas like Hanare, which opened in Brooklyn in January, are gaining popularity, while Kristen Lo Sicco, MD, associate professor, the Ronald O. Perelman Department of Dermatology, chief, service and director, Skin and Cancer Unit, cautions against aggressive treatments for those with scalp conditions like eczema or hair loss, as procedures using microneedling or essential oils can worsen these conditions.

GLP-1RAs Likely Do Not Increase Risk For Suicidality. (Endocrinology Advisor)

(4/30) A systematic review and meta-analysis published in JAMA Psychiatry by researchers from ���ϸ����� Grossman School of Medicine found no significant association between GLP-1 receptor agonist treatment and increased risk of suicidality among adults with diabetes, overweight, or obesity, based on data from 31 randomized controlled trials.

Experts Discover That Your Daily Step Count Has A Huge Impact On Your Mental Health – Here’s The Ideal Number. (Women's Health)

(4/30) Thea Gallagher, PsyD, clinical assistant professor, Department of Psychiatry, discusses research into links between daily step counts and mental health.

What Happens If You Don’t Wash Your Face? (TIME)

(4/30) Dermatologists, including Nicole M. Golbari, MD, MPH, clinical associate professor, Department of Medicine, ���ϸ����� Langone Hospital—Long Island, caution against the “caveman method” of not washing the face, saying, “Skin bacteria thrive off those clogged pores, which leads to inflammatory pimples, pustules and cysts.”

The Residency Report: Study Provides New Insights Into USH2A Target End Points. (Opthalmology Times)

(4/30) posts the Residency Report, a partnership between the Department of Ophthalmology at the ���ϸ����� Grossman School of Medicine and Ophthalmology Times, focuses on “clinical trial end points in patients with Usher syndrome type 2 (USH2A)–related retinal degeneration.”

���ϸ����� Langone Health’s LaPook Discusses Research Suggesting Wegovy’s Use In Treating Liver Disease. (CBS)

(5/1) ���ϸ����� Langone Health’s Jonathan D. LaPook, MD, the Mebane Professor of Gastroenterology, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health discusses researching suggesting the main ingredient of Wegovy and Ozempic could be used to treat liver disease.

Summer Health Trends. (WNBC-TV New York)

(4/30) Natalie E. Azar, MD, Department of Medicine, Division of Rheumatology, clarified several health misconceptions on a TODAY health segment, including the fact that higher SPF sunscreen offers only marginally more protection beyond SPF 30, and that most people naturally obtain sufficient electrolytes from their diet unless engaging in strenuous activities.

Immigrants Do Not Threaten America’s Health: Ethicist. (Medscape)

(4/30)* Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, stated in a commentary on Wednesday, that the political rhetoric surrounding immigrants posing a health threat to Americans is false, noting that “there is no evidence that any immigrants ... are bringing in more coronavirus, tuberculosis, or measles.”